Below is a breakdown of the top cannabis news stories for August 3, 2026, with each title linking to a full article. The Marijuana Herald publishes a new edition every weekday at around 3 p.m. Pacific Time. This, and future editions, can be found by clicking here.
Clinical Trial: CBD Provided Pain Relief Comparable to Codeine-Acetaminophen After Laser Eye Surgery
Oral CBD provided pain relief comparable to codeine-acetaminophen following laser eye surgery in a randomized crossover clinical trial involving 35 adults. Researchers found no significant differences in average or maximum pain ratings, recovery outcomes or most side effects between the treatments. The treatment also lasted longer than codeine it’s pain-relieve effect.
CBD Nanoparticles Suppressed Liver Tumor Growth in New Study
CBD delivered through specially designed nanoparticles significantly inhibited liver tumor growth in a preclinical study, producing results comparable to the chemotherapy drug cyclophosphamide. The delivery system increased CBD’s apparent water solubility by 367 times and allowed it to accumulate more effectively within tumors.
CBD Oil Was Well Tolerated in Dogs With Osteoarthritis, Clinical Trial Finds
CBD oil was generally well tolerated in a randomized, placebo-controlled clinical trial involving 10 dogs with osteoarthritis. Changes in pain scores were modest and variable, and researchers said larger trials involving between 24 and 132 dogs may be needed to reliably determine its effectiveness.
D.C. Mayor Signs Medical Cannabis Licensing and Enforcement Bill Into Law
D.C. Mayor Muriel Bowser has signed emergency legislation extending conditional medical marijuana licenses from two years to as long as three years. The law also expands regulators’ authority to close and padlock businesses selling marijuana or other controlled substances without authorization.
Florida Medical Marijuana Sales Reach Record $198.2 Million in July, Near $1.2 Billion in 2026
Florida medical marijuana dispensaries generated a record $198.2 million in sales in July, surpassing the previous monthly high by approximately $18.5 million. The state’s medical marijuana market has now produced approximately $1.19 billion in sales through the first seven months of 2026.
New York Cannabis Regulators Seize More Than $17 Million in Largest Enforcement Action in Agency History
New York cannabis regulators and the Greece Police Department seized more than $17 million worth of illicit marijuana products and processing equipment in the largest enforcement action in Office of Cannabis Management history. Authorities confiscated hundreds of pounds of marijuana flower and thousands of pounds of edibles and concentrates, including products labeled with THC levels far above state limits.
Marijuana Legalization Did Not Increase Youth Hospitalizations in Manitoba, Study Finds
Marijuana legalization did not lead to a statistically significant increase in marijuana-related hospitalizations among children and teenagers in Manitoba. The average number of monthly hospitalizations was 8.50 before legalization, 9.52 during its initial phase and 8.59 during the second phase.
New York Bill Expanding Marijuana Microbusiness Role in Showcase Events Sent to Governor
Legislation allowing licensed marijuana microbusinesses to take on a larger role in New York cannabis showcase events has been delivered to New York Governor Kathy Hochul. The measure would allow qualifying microbusinesses to serve as the retailer, cultivator and processor required for an event, with Hochul given until August 12 to act.
Prenatal Marijuana Use Not Linked to Increased Risk of Childhood Anxiety or Depression, Study Finds
Marijuana use during early pregnancy was not associated with an increased risk of childhood anxiety or depressive disorders in a study involving more than 115,000 children. The children were followed from age 6 through as late as age 13, although researchers stressed that the findings do not establish that marijuana use during pregnancy is safe.
Sponsors:
